Literature DB >> 2858451

Isolation, purification, and partial characterization of an enterotoxin from extracts of Entamoeba histolytica trophozoites.

C Feingold, R Bracha, A Wexler, D Mirelman.   

Abstract

Soluble cell-free extracts of pathogenic Entamoeba histolytica, as well as serum-free minimal media in which trophozoites are incubated, contain substances that cause the rapid rounding up and detachment of tissue-cultured monolayers of mammalian cells (cytopathic activity) and induce fluid secretion in ligated intestinal loops of indomethacin-pretreated rats (enterotoxic activity). A semiquantitative assay for the determination of the cytopathic activity based on the rate of detachment of tissue-cultured baby hamster kidney cells was developed. Two peaks containing cytopathic activity were obtained upon gel filtration of the soluble extracts: peak I, with over 60% of the activity, emerged in the 30,000 to 50,000 molecular weight region, and peak II, containing the remaining activity, was in the 15,000 to 25,000 molecular weight region. The activity of peak I was found to be heat labile and inhibited by sialoglycoproteins such as fetuin and mucin (5 mg/ml), as well as by sialic acid. Protease inhibitors such as antitrypsin, pepstatin, phenylmethylsulfonyl fluoride, metaloprotease inhibitors, and bacitracin had no effect on the cytopathic activity. Marked inhibition of cytopathic activity was observed, however, with iodoacetamide and p-chloromercuribenzoate, which affect sulfhydryl groups. The toxic material in peak II was found to have ionophoric activity and was not inhibited by sialic acid-containing compounds. The materials from both peaks had enterotoxic activity in intestinal ligated loops. The active substance from peak I was further purified (200X) on an agarose-fetuin affinity column, yielding one major protein band with an apparent molecular weight of ca. 30,000 on sodium dodecyl sulfate. Amino acid analysis revealed that the protein was very poor in sulfur amino acids. The sialic acid-sensitive toxic activity was higher in known virulent strains such as HM-1:IMSS and could be markedly augmented after preincubation of the trophozoites with certain Escherichia coli strains.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2858451      PMCID: PMC261937          DOI: 10.1128/iai.48.1.211-218.1985

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  37 in total

1.  THE TOXIC EFFECT OF ENTAMOEBA HISTOLYTICA ON LEUCOCYTES.

Authors:  R JARUMILINTA; F KRADOLFER
Journal:  Ann Trop Med Parasitol       Date:  1964-09

2.  Fine structural changes at Entamoeba histolytica rabbit kidney cell (RK 13) interface.

Authors:  R Knight; R G Bird; T F McCaul
Journal:  Ann Trop Med Parasitol       Date:  1975-06

3.  Virulence and toxicity of axenic Entamoeba histolytica.

Authors:  H J Bos; R J van de Griend
Journal:  Nature       Date:  1977-01-27       Impact factor: 49.962

4.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

5.  Pathology of human amebiasis.

Authors:  H Brandt; R P Tamayo
Journal:  Hum Pathol       Date:  1970-09       Impact factor: 3.466

6.  Studies on the chemical and enzymatic modification of glycoproteins. A general method for the tritiation of sialic acid-containing glycoproteins.

Authors:  L Van Lenten; G Ashwell
Journal:  J Biol Chem       Date:  1971-03-25       Impact factor: 5.157

7.  Role of bacteria in modifying virulence of Entamoeba histolytica. Studies of amebae from axenic cultures.

Authors:  M Wittner; R M Rosenbaum
Journal:  Am J Trop Med Hyg       Date:  1970-09       Impact factor: 2.345

8.  Effects of different species of bacteria on the pathology of enteric amebiasis in monocontaminated guinea pigs.

Authors:  B P Phillips; F Gorstein
Journal:  Am J Trop Med Hyg       Date:  1966-11       Impact factor: 2.345

9.  Interaction of Vibrio cholerae enterotoxin with cell membranes.

Authors:  P Cuatrecasas
Journal:  Biochemistry       Date:  1973-08-28       Impact factor: 3.162

10.  The functional morphology of pathogenicity in Entamoeba histolytica.

Authors:  R D Eaton; E Meerovitch; J W Costerton
Journal:  Ann Trop Med Parasitol       Date:  1970-09
View more
  8 in total

1.  Cytopathology of pathogenic and nonpathogenic Naegleria species for cultured rat neuroblastoma cells.

Authors:  F M Marciano-Cabral; D E Fulford
Journal:  Appl Environ Microbiol       Date:  1986-05       Impact factor: 4.792

Review 2.  Ameba-bacterium relationship in amebiasis.

Authors:  D Mirelman
Journal:  Microbiol Rev       Date:  1987-06

3.  Proteinases resistant to sodium dodecyl sulfate-induced autoproteolysis of Entamoeba histolytica HK9 trophozoites.

Authors:  R López-Revilla; L Canto-Ortiz; B Jiménez-Delgadillo; L Chávez-Dueñas
Journal:  Parasitol Res       Date:  1993       Impact factor: 2.289

4.  Chinese hamster ovary cells deficient in N-acetylglucosaminyltransferase I activity are resistant to Entamoeba histolytica-mediated cytotoxicity.

Authors:  E Li; A Becker; S L Stanley
Journal:  Infect Immun       Date:  1989-01       Impact factor: 3.441

5.  Dose- and time-dependent functional and structural damage to the colon mucosa by Entamoeba histolytica trophozoite lysates.

Authors:  F Navarro-García; R López-Revilla; V Tstusumi
Journal:  Parasitol Res       Date:  1993       Impact factor: 2.289

6.  Rat and human colonic mucins bind to and inhibit adherence lectin of Entamoeba histolytica.

Authors:  K Chadee; W A Petri; D J Innes; J I Ravdin
Journal:  J Clin Invest       Date:  1987-11       Impact factor: 14.808

7.  Affinity purification and biochemical characterization of histolysin, the major cysteine proteinase of Entamoeba histolytica.

Authors:  A L Luaces; A J Barrett
Journal:  Biochem J       Date:  1988-03-15       Impact factor: 3.857

8.  The major neutral proteinase of Entamoeba histolytica.

Authors:  W E Keene; M G Petitt; S Allen; J H McKerrow
Journal:  J Exp Med       Date:  1986-03-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.